Home
Live Updates
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement : comparemela.com
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Achilles ADSs will continue to trade on the Nasdaq Global Select Market at this time, and the Company's operations are not affected by the receipt of
Related Keywords
London ,
City Of ,
United Kingdom ,
United States ,
American ,
Achilles Adss ,
Sukaina Virji ,
Dylan Wilks ,
Tracy Cheung ,
Company Adss ,
Company American Depositary ,
Nasdaq Stock Market ,
Nasdaq ,
Nasdaq Global Select Market ,
American Depositary Shares ,
Nasdaq Listing Rule ,
Bid Price ,
Minimum Bid Price Requirement ,
Minimum Bid Price ,
Compliance Deadline ,
Achilles ,
Herapeutics ,
Eceives ,
Deficiency ,
Notice ,
Egarding ,
Minimum ,
Price ,
Requirement ,
Index ,
Wall Street ,
Exchange ,
Trading ,
comparemela.com © 2020. All Rights Reserved.